Amglidia

glibenclamide · Ammtek

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Amglidia, covering 2023-12-06 to 2023-12-06. Get the full timeline:

Most recent: EMA Authorised: Amglidia (glibenclamide) — Ammtek